These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 25500745)

  • 1. Using Cost-Effectiveness Analysis to Address Health Equity Concerns.
    Cookson R; Mirelman AJ; Griffin S; Asaria M; Dawkins B; Norheim OF; Verguet S; J Culyer A
    Value Health; 2017 Feb; 20(2):206-212. PubMed ID: 28237196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness uncertainty may bias the decision of coal power transitions in China.
    Yan X; Tong D; Zheng Y; Liu Y; Chen S; Qin X; Chen C; Xu R; Cheng J; Shi Q; Zheng D; He K; Zhang Q; Lei Y
    Nat Commun; 2024 Mar; 15(1):2272. PubMed ID: 38480703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health Equity: A Call to Action for Innovators, Clinical Leaders, and Policymakers.
    Johnson AE; Grant JK; Contreras JP; Grant AJ; Joynt Maddox K; Sengupta PP; Iluyomade A; Ogunniyi MO
    JACC Adv; 2024 Jul; 3(7):100982. PubMed ID: 39129996
    [No Abstract]   [Full Text] [Related]  

  • 4. Equity weighting increases the social cost of carbon.
    Prest BC; Rennels L; Errickson F; Anthoff D
    Science; 2024 Aug; 385(6710):715-717. PubMed ID: 39146409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatiotemporal heterogeneity of the association between socioeconomic development and health policy attention: a geographically and temporally weighted regression modeling study in China.
    He R; Wang H; Liang W
    Front Public Health; 2024; 12():1338142. PubMed ID: 39257954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unravelling Elements of Value of Healthcare and Assessing their Importance Using Evidence from Two Discrete-Choice Experiments in England.
    Gongora-Salazar P; Perera R; Rivero-Arias O; Tsiachristas A
    Pharmacoeconomics; 2024 Oct; 42(10):1145-1159. PubMed ID: 39085565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the Healthy China 2030 Policy Improve People's Health? Empirical Evidence Based on the Difference-in-Differences Approach.
    Ning C; Pei H; Huang Y; Li S; Shao Y
    Risk Manag Healthc Policy; 2024; 17():65-77. PubMed ID: 38204928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Priority setting in the German healthcare system: results from a discrete choice experiment.
    Meusel V; Mentzakis E; Baji P; Fiorentini G; Paolucci F
    Int J Health Econ Manag; 2023 Sep; 23(3):411-431. PubMed ID: 37184821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Practices for Accounting for Preference Heterogeneity in Health-Related Discrete Choice Experiments: A Systematic Review.
    Karim S; Craig BM; Vass C; Groothuis-Oudshoorn CGM
    Pharmacoeconomics; 2022 Oct; 40(10):943-956. PubMed ID: 35960434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Balancing Equity and Efficiency in the Allocation of Health Resources-Where Is the Middle Ground?
    Asamani JA; Alugsi SA; Ismaila H; Nabyonga-Orem J
    Healthcare (Basel); 2021 Sep; 9(10):. PubMed ID: 34682937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Education, Medical Services, and Living Conditions on Health: Evidence from China Health and Nutrition Survey.
    Dai X; Li W
    Healthcare (Basel); 2021 Aug; 9(9):. PubMed ID: 34574896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes of patients and surgeons towards sham surgery trials: a protocol for a scoping review of attributes to inform a discrete choice experiment.
    Wall L; Hinwood M; Lang D; Smith A; Bunzli S; Clarke P; Choong PFM; Dowsey MM; Paolucci F
    BMJ Open; 2020 Mar; 10(3):e035870. PubMed ID: 32161162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Public Health Expenditure on Health Outcomes in South Africa.
    Hlafa B; Sibanda K; Hompashe DM
    Int J Environ Res Public Health; 2019 Aug; 16(16):. PubMed ID: 31434254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrete Choice Experiments in Health Economics: Past, Present and Future.
    Soekhai V; de Bekker-Grob EW; Ellis AR; Vass CM
    Pharmacoeconomics; 2019 Feb; 37(2):201-226. PubMed ID: 30392040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicriteria decision analysis (MCDA) in health care: a systematic review of the main characteristics and methodological steps.
    Frazão TDC; Camilo DGG; Cabral ELS; Souza RP
    BMC Med Inform Decis Mak; 2018 Nov; 18(1):90. PubMed ID: 30382826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of discrete choice experiments to enhance stakeholder engagement as a strategy for advancing implementation: a systematic review.
    Salloum RG; Shenkman EA; Louviere JJ; Chambers DA
    Implement Sci; 2017 Nov; 12(1):140. PubMed ID: 29169397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using Latent Class Analysis to Model Preference Heterogeneity in Health: A Systematic Review.
    Zhou M; Thayer WM; Bridges JFP
    Pharmacoeconomics; 2018 Feb; 36(2):175-187. PubMed ID: 28975582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficiency and equity considerations in the preferences of health policy-makers in Israel.
    Shmueli A; Golan O; Paolucci F; Mentzakis E
    Isr J Health Policy Res; 2017; 6():18. PubMed ID: 28373904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equity and efficiency preferences of health policy makers in China--a stated preference analysis.
    Paolucci F; Mentzakis E; Defechereux T; Niessen LW
    Health Policy Plan; 2015 Oct; 30(8):1059-66. PubMed ID: 25500745
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.